Chris Coons actually said...

"I think it is going to be a challenge to educate."

"The R&D tax credit has made a huge difference, particularly for very large and very profitable companies, over a long period of time."

"I think biochemical, pharmaceutical, I think anything in the medical field will all be very good targets for this."

"That will be a massive change. We had it in 2010 for one year. It was just a sea change for folks being able to take it across the board."